title: Ghrelin strongly stimulates growth hormone release in humans.
abstract: Ghrelin is a recently identified endogenous ligand for the GH secretagogue receptor and is involved in a novel system for regulating GH release. However, little is known about its GH-releasing activity and other endocrine effects in humans. To address this issue, we studied the GH, ACTH, cortisol, PRL, LH, FSH, and TSH responses to synthetic human ghrelin. In four normal male adults (28-37 yr), iv ghrelin administration released GH in a dose-dependent manner and 0.2, 1.0, and 5.0 microg/kg ghrelin produced 43.3 +/- 6.0, 81.5 +/- 12.7, and 107.0 +/- 10.7 ng/mL of the GH peak values at 30 min, respectively. ACTH, cortisol, and PRL levels were also elevated after ghrelin injection, while the lowest dose (0.2 microg/kg) resulted in only minimum peak values of these hormones (22.8 +/- 3.0 pg/mL, 9.4 +/- 1.9 microg/dL, and 4.6 +/- 0.6 ng/mL, respectively). There were no significant changes in LH, FSH, or TSH levels. This is the first study showing evidence that ghrelin strongly stimulates GH release in humans.
authors.affiliation: Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Takaya
authors.forename: H
authors.initials: H
authors.lastname: Ariyasu
authors.forename: N
authors.initials: N
authors.lastname: Kanamoto
authors.forename: H
authors.initials: H
authors.lastname: Iwakura
authors.forename: A
authors.initials: A
authors.lastname: Yoshimoto
authors.forename: M
authors.initials: M
authors.lastname: Harada
authors.forename: K
authors.initials: K
authors.lastname: Mori
authors.forename: Y
authors.initials: Y
authors.lastname: Komatsu
authors.forename: T
authors.initials: T
authors.lastname: Usui
authors.forename: A
authors.initials: A
authors.lastname: Shimatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Ogawa
authors.forename: K
authors.initials: K
authors.lastname: Hosoda
authors.forename: T
authors.initials: T
authors.lastname: Akamizu
authors.forename: M
authors.initials: M
authors.lastname: Kojima
authors.forename: K
authors.initials: K
authors.lastname: Kangawa
authors.forename: K
authors.initials: K
authors.lastname: Nakao
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D004305:Dose-Response Relationship, Drug; D005640:Follicle Stimulating Hormone / Q000097:blood; D054439:Ghrelin; D019382:Human Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D036361:Peptide Hormones; D010455:Peptides / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood; D011994:Recombinant Proteins / Q000494:pharmacology; D013997:Time Factors
chemical_list: D054439:Ghrelin; D036361:Peptide Hormones; D010455:Peptides; D011994:Recombinant Proteins; D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone